Article
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
13 Oct 2021
Abstract excerpt
Progress made during the last decade in stem cell biology allows currently an unprecedented potential to translate these advances into the clinical applications and to shape the future of regenerative medicine. Organoid technology is amongst these major developments, derived from primary tissues or more recently, from induced pluripotent stem cells (iPSC). The use of iPSC technology offers the possibility of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
